Advertisement

The Latest

Ohio State University and Indiana University researchers took a closer look at delays in cancer screenings brought on by COVID-19, revealing that as high as 36 percent of certain screenings were delayed.

St. Louis-based Mercy is among the first to offer a simple blood test to detect hard-to-diagnose cancers at the molecular level — before it’s too late. The test is currently available in 11 Mercy hospital labs across three states.

Here are five oncology partnerships formed since Nov. 16:

Advertisement